Skip to content

Evaluation of the therapeutic effect and mechanism exploration of multi-target-oriented microecological nutritional compound on pediatric tic disorders

Evaluation of the therapeutic effect and mechanism exploration of multi-target-oriented microecological nutritional compound on pediatric tic disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100133
Enrollment
Unknown
Registered
2025-04-03
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric tic disorders

Interventions

The micro ecological nutrition mixture group:The micro ecological nutrition mixture group took the micro ecological nutrition mixture (8g/strip/time, 2 times/day) for 16 weeks.
The placebo group:The placebo group received maltodextrin at 8g/strip/time, twice a day, for 16 weeks.

Sponsors

the Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1.Age 3-10 years old (including 3 and 10 years old), regardless of gender; 2.Patients who met the diagnostic criteria of DSM-V and YGTSS (combined motor tic and vocal tic score, 100 points in total). 3.Patients with mild to moderate TD whose course of disease was more than 3 months and YGTSS score was less than or equal to 50. 4.The medication indications were not met and the parents were unwilling to use medication. 5.The guardian can cooperate to complete the corresponding assessment.

Exclusion criteria

Exclusion criteria: 1.Non autonomous exercisers who can be explained by other diseases, such as rheumatic diseases, Huntington's disease, Wilson's disease, hand foot hyperkinesia, muscle spasms, acute motor disorders, spasms of hysteria, epilepsy and childhood schizophrenia, drug-induced extrapyramidal symptoms, and other extrapyramidal diseases. 2.Children with other unstable or severe heart, lung, liver, kidney, hematopoietic system diseases (including unstable angina, uncontrolled asthma, active gastric bleeding, cancer, etc.); 3.Within one month prior to enrollment, received antibiotics, probiotics, ketogenic diet, fecal microbiota transplantation, proton pump inhibitors, and other treatment plans that affect the gastrointestinal tract, as well as other related TD treatment plans (including any treatment).

Design outcomes

Primary

MeasureTime frame
Yale Comprehensive Tourette Syndrome Severity Scale (YGTSS) Score;

Secondary

MeasureTime frame
Child Behavior Checklist (CBCL) Score;Children's Yale Brown Obsessive Compulsive Scale (CYBOCS) Score;Children's Multidimensional Anxiety Scale (MASC) Score;Children's Depression Inventory (CDI) Score; Gastrointestinal Symptom Rating Scale (GSRS) Score;

Countries

China

Contacts

Public ContactLin Chuhui

the Second Affiliated Hospital of Guangzhou Medical University

175586863@qq.com+86 20 3415 2396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026